Venous thromboembolism in COVID-19: A meta-summary of cases

Naif Saad ALGhasab1, Leen A Altamimi1, Mohammed Salem Alharbi1

  • 1From the Department of Internal Medicine (ALGhasab), Medical Collage, Ha'il University; from the Department of Medicine (Alharbi), College of Medicine, University of Ha'il, Ha'il; from the College of Medicine (Altamimi), King Saud University, Riyadh; from the Department of Surgery (ALMesned), Medical College, Qassim University, Buraydah, Kingdom of Saudi Arabia; and from the Department of Medicine (ALGhasab, Khetan), McMaster University, Canada.

Saudi Medical Journal
|September 14, 2022
PubMed

Insights

Venous thromboembolism (VTE), including pulmonary embolism (PE) and deep vein thrombosis (DVT), is a significant concern in COVID-19 patients. Early suspicion and diagnosis are crucial, even in those on anticoagulation, to improve patient outcomes.

Area of Science:

  • Medical Research
  • Infectious Diseases
  • Cardiology

Background:

  • Coronavirus disease (COVID-19) has been associated with an increased risk of venous thromboembolism (VTE).
  • Understanding the clinical presentation, risk factors, and outcomes of VTE in COVID-19 patients is critical for effective management.

Purpose of the Study:

  • To summarize cases of VTE (pulmonary embolism and deep vein thrombosis) in COVID-19 patients.
  • To discuss the symptoms, diagnostic methods, clinical features, and prognosis of VTE in this population.

Main Methods:

  • A comprehensive literature search was conducted across major databases.
  • Studies published between December 1, 2019, and May 5, 2021, were included.

Main Results:

  • Twenty-two articles describing 48 COVID-19 patients with VTE were analyzed.
  • The majority of patients (79.1%) had pulmonary embolism (PE), and 20.9% had deep vein thrombosis (DVT).
  • Comorbidities were common (70.8%), and 85.4% had VTE risk factors; 56.3% received anticoagulation, yet complications occurred in 27.1%.

Conclusions:

  • VTE should be suspected in COVID-19 patients, particularly males, the elderly, and those with comorbidities or elevated D-dimer levels.
  • VTE must be considered even in patients receiving anticoagulation or presenting with stable disease.
  • Prompt diagnosis and management are essential, as 80.4% of patients achieved recovery.
Abstract

Related Concept Videos

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies01:20

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
29
Venous Thrombosis I: Introduction01:30

Venous Thrombosis I: Introduction

Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
37
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
18
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
36
Pulmonary Embolism I: Introduction01:29

Pulmonary Embolism I: Introduction

Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
35
Venous Thrombosis IV: Nursing Management01:30

Venous Thrombosis IV: Nursing Management

Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
19